Literature DB >> 1922963

Screening for the beta-amyloid precursor protein mutation (APP717: Val----Ile) in extended pedigrees with early onset Alzheimer's disease.

M C Chartier-Harlin1, F Crawford, K Hamandi, M Mullan, A Goate, J Hardy, H Backhovens, J J Martin, C V Broeckhoven.   

Abstract

Screening for the APP717 mutation in 5 further families with early onset Alzheimer's disease failed to reveal further cases with this variant. Screening a further 100 normal individuals for this mutation also failed to reveal further occurrences of this variant in the general population. Sequencing of exons 16 and 17 of the beta-amyloid precursor protein gene (the exons which encode the beta-amyloid fragment) in pedigree FAD4 revealed them to be of normal sequence. The significance of these observations to the genetics of Alzheimer's disease is discussed.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1922963     DOI: 10.1016/0304-3940(91)90738-f

Source DB:  PubMed          Journal:  Neurosci Lett        ISSN: 0304-3940            Impact factor:   3.046


  17 in total

Review 1.  Vaccines for Alzheimer's disease: how close are we?

Authors:  Christopher Janus
Journal:  CNS Drugs       Date:  2003       Impact factor: 5.749

2.  Alzheimer disease: the new agenda.

Authors:  J Hardy; M C Chartier-Harlin; M Mullan
Journal:  Am J Hum Genet       Date:  1992-03       Impact factor: 11.025

Review 3.  Actin dynamics and cofilin-actin rods in alzheimer disease.

Authors:  James R Bamburg; Barbara W Bernstein
Journal:  Cytoskeleton (Hoboken)       Date:  2016-03-01

4.  Assessment of amyloid beta-protein precursor gene mutations in a large set of familial and sporadic Alzheimer disease cases.

Authors:  R E Tanzi; G Vaula; D M Romano; M Mortilla; T L Huang; R G Tupler; W Wasco; B T Hyman; J L Haines; B J Jenkins
Journal:  Am J Hum Genet       Date:  1992-08       Impact factor: 11.025

Review 5.  The role of the amyloid protein precursor (APP) in Alzheimer's disease: does the normal function of APP explain the topography of neurodegeneration?

Authors:  D H Small
Journal:  Neurochem Res       Date:  1998-05       Impact factor: 3.996

Review 6.  Genetic heterogeneity of gene defects responsible for familial Alzheimer disease.

Authors:  R Tanzi; S Gaston; A Bush; D Romano; W Pettingell; J Peppercorn; M Paradis; S Gurubhagavatula; B Jenkins; W Wasco
Journal:  Genetica       Date:  1993       Impact factor: 1.082

7.  Pterostilbene ameliorates intracerebroventricular streptozotocin induced memory decline in rats.

Authors:  Bhagyashree Naik; Abhijit Nirwane; Anuradha Majumdar
Journal:  Cogn Neurodyn       Date:  2016-09-30       Impact factor: 5.082

8.  Therapeutic perspectives of drugs targeting Toll-like receptors based on immune physiopathology theory of Alzheimer's disease.

Authors:  Andrew R Schneider; Youssef Sari
Journal:  CNS Neurol Disord Drug Targets       Date:  2014       Impact factor: 4.388

Review 9.  Cytoskeletal pathologies of Alzheimer disease.

Authors:  James R Bamburg; George S Bloom
Journal:  Cell Motil Cytoskeleton       Date:  2009-08

10.  Linkage and mutational analysis of familial Alzheimer disease kindreds for the APP gene region.

Authors:  K Kamino; H T Orr; H Payami; E M Wijsman; M E Alonso; S M Pulst; L Anderson; S O'dahl; E Nemens; J A White
Journal:  Am J Hum Genet       Date:  1992-11       Impact factor: 11.025

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.